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Distribution of α7 Nicotinic
Acetylcholine Receptor Subunit
mRNA in the Developing Mouse
Ron S. Broide1†‡, Ursula H. Winzer-Serhan2*†, Yling Chen1 and Frances M. Leslie1
1 Department of Pharmacology, University of California, Irvine, Irvine, CA, United States, 2 Department of Neuroscience
and Experimental Therapeutics, Texas A&M University College of Medicine, Bryan, TX, United States
Homomeric α7 nicotinic acetylcholine receptors (nAChRs) are abundantly expressed in
the central and peripheral nervous system (CNS and PNS, respectively), and spinal cord.
In addition, expression and functional responses have been reported in non-neuronal
tissue. In the nervous system, α7 nAChR subunit expression appears early during
embryonic development and is often transiently upregulated, but little is known about
their prenatal expression outside of the nervous system. For understanding potential
short-term and long-term effects of gestational nicotine exposure, it is important to know
the temporal and spatial expression of α7 nAChRs throughout the body. To that end,
we studied the expression of α7 nAChR subunit mRNA using highly sensitive isotopic
in situ hybridization in embryonic and neonatal whole-body mouse sections starting at
gestational day 13. The results revealed expression of α7 mRNA as early as embryonic
day 13 in the PNS, including dorsal root ganglia, parasympathetic and sympathetic
ganglia, with the strongest expression in the superior cervical ganglion, and low to
moderate levels were detected in brain and spinal cord, respectively, which rapidly
increased in intensity with embryonic age. In addition, robust α7 mRNA expression was
detected in the adrenal medulla, and low to moderate expression in selected peripheral
tissues during embryonic development, potentially related to cells derived from the
neural crest. Little or no mRNA expression was detected in thymus or spleen, sites
of immune cell maturation. The results suggest that prenatal nicotine exposure could
potentially affect the nervous system with limited effects in non-neural tissues.
Keywords: cortex, hippocampus, spinal cord, enteric nervous system, adrenal medulla, kidney, dorsal root
ganglia, nicotine
INTRODUCTION
Nicotinic acetylcholine receptors (nAChRs) are ligand gated pentameric cation channels, which
were first identified in Torpedo electric organ, and are found in vertebrate and non-vertebrate
animals (Changeux, 2012). The nAChRs can be broadly classified into muscle and neuronal type
nAChRs, based on the compositions of the subunits that form the ion channel. The neuronal type
nAChRs exhibit great diversity, and heteromeric receptors are formed by various compositions of
alpha (α2–α10) and non-alpha (β2–β4) subunits. In addition, the α7 subunit forms homomeric
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pentamers which have high permeability for calcium ions
(Papke, 2014; Kabbani and Nichols, 2018).
Neuronal nAChRs are widely distributed in the peripheral
(PNS), central (CNS), and enteric (ENS) nervous system, sensory
neurons, retina, and in the adrenal medulla. In the brain
and spinal cord, α4 and β2 subunits are broadly expressed,
and form the widely distributed neuronal heteromeric nAChR
that displays high affinity for nicotine, and is primarily
located on presynaptic terminals (Papke, 2014). Knock-out
of either α4 or β2 mRNAs results in an almost complete
loss of high affinity nicotine binding sites in the brain
(Baddick and Marks, 2011). Homomeric α7 nAChRs, which
are distinguished from neuronal heteromeric nAChRs by
their high-affinity binding to α-Bungarotoxin (α-BTX), are
also abundantly expressed in the CNS and spinal cord,
where they are located at pre-and postsynaptic sites (Tribollet
et al., 2004). During development, mRNA expression of
several subunits is transiently upregulated, both in terms
of intensity and spatial distribution, and different nAChR
subtypes may take on specific functions relevant for brain
development (Winzer-Serhan and Leslie, 1997, 2005; Broide
and Leslie, 1999; Adams et al., 2002; Son and Winzer-Serhan,
2006). In the PNS, nAChRs exert essential functions in the
regulation of the sympathetic and parasympathetic nervous
systems. Moreover, neuronal nAChRs are expressed at high
levels in peripheral ganglia, where heteromeric nAChRs are
predominantly found (Wang et al., 2002). Homomeric α7
nAChRs are also detected in the periphery, but their functional
role in either the PNS or ENS, particularly during development,
is still unclear.
For a long time, the consensus was that neuronal nAChRs
are expressed exclusively on neurons. However, in recent years it
has become increasingly clear that functional nAChR responses
can be found in non-excitable cells, including microglia (Shytle
et al., 2004; Suzuki et al., 2006), astrocytes (Papouin et al.,
2017), Schwann cells (Petrov et al., 2014), and other non-
neuronal tissues (Sharma and Vijayaraghavan, 2002), and that
these responses are often mediated by α7 nAChRs. Of particular
interest is the expression of α7 nAChRs in the immune system,
because of its crucial role in the regulation of the cholinergic anti-
inflammatory pathway (Wang et al., 2003). Based on findings
from previous studies, neuronal nAChR subunits appear early
during brain development (Zoli et al., 1995; Adams et al.,
2002; Tribollet et al., 2004). However, at present, little is
known about the expression of α7 nAChRs outside of the CNS,
especially during embryonic development. To better understand
the potential developmental roles of α7 nAChRs, and the
possible short-term and long-term effects of gestational nicotine
exposure, we used highly sensitive isotopic in situ hybridization
(Winzer-Serhan et al., 1999) to identify α7 nAChR expression
in embryonic and neonatal whole-body mouse sections. The
results of this study revealed the expression of α7 mRNA as
early as embryonic day 13 in the peripheral nervous system,
including dorsal root ganglia, parasympathetic and sympathetic
ganglia, followed by strong expression in brain and spinal cord. In
addition, α7 subunit mRNA expression was detected in a number
of peripheral tissues potentially related to cells derived from the
neural crest. In contrast, little or no expression was detected in
thymus or spleen, sites of immune cell maturation.
MATERIALS AND METHODS
The following materials were obtained from the sources
indicated: bovine serum albumin, ficoll, polyvinylpyrrolidone,
poly-L-lysine, and RNase A (Sigma Chemical Co., St. Louis, MO,
United States); T3 and T7 RNA polymerases, proteinase K, and
yeast tRNA (Roche Molecular); formamide (Fluka, Ronkonkoma,
NY, United States); dextran sulfate and Hyperfilm Bmax
(Amersham Pharmacia, Arlington Heights, IL, United States);
nuclear track emulsion (NTB-2), (Kodak, Rochester, NY,
United States); [35S]uridine triphosphate (UTP) (Life Science
NEN, Boston, MA, United States).
Tissue Preparation
Male and female mice (C57BL/6; Charles River, Wilmington, MA,
United States) were group housed and provided with food and
water ad libitum. The mice were mated over a 4-day period and
females were monitored twice daily (morning and afternoon)
for vaginal plugs. The day of mating (presence of a plug) was
defined as embryonic day (E) 0 and pups were born on E19.
Pregnant female mice were killed by decapitation and their
embryos removed at E13, E15, and E17. Select embryonic pups
were taken from different litters and their sex was identified
whenever possible. Embryonic and postnatal day (P) 0 mice
were anesthetized on ice for several minutes before being frozen
whole in isopentane at –25◦C and stored at −80◦C until use.
These procedures were approved by the Institutional Animal
Care and Use Committee at the University of California, Irvine,
in accordance with federal guidelines. Mouse pups (n = 2–3/age)
were cryostat sectioned (20 µm) in the sagittal plane from the
lateral right side of the body until just past the midline. Tissue
sections were mounted onto slides which were coated with either
1% gelatin (for histology) or an additional coating of poly-L-
lysine (for in situ hybridization) and kept at –20◦C. Sections
were post-fixed with 4% paraformaldehyde in 0.1 M phosphate
buffered saline (PBS), pH 7.4 for 1 h at 22◦C, then washed in PBS,
air dried and stored desiccated at−20◦C until use.
cRNA Probe Preparation and in situ
Hybridization
cRNA riboprobes labeled with [35S]UTP were prepared
from a 279 bp PstI restriction DNA fragment encoding
the third intracellular loop of the mouse α7 nAChR subunit
(NM_007390.3; nucleotide sequence 1140 to 1419) (Orr-Urtreger
et al., 1995). Riboprobes targeted to this region have been used
previously to characterize α7 mRNA distribution in developing
mice (Orr-Urtreger et al., 2000; Broide et al., 2001) and show the
same pattern of expression as those observed using riboprobes
targeted to either the 3′ non-coding region or the full-length
mouse α7 nAChR cDNA (data not shown). Post-fixed whole-
body sections were processed according to a published protocol
(Winzer-Serhan et al., 1999). Briefly, slide-mounted sections
were first preincubated with 0.1 µg/ml proteinase K for 10 min at
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22◦C, and then incubated for 18 h at 60◦C with a hybridization
solution (50% formamide, 10% dextran sulfate, 0.02% Ficoll,
0.02% polyvinyl pyrrolidone, 0.02% bovine serum albumin,
500 µg/ml tRNA, 10 mM dithiothreitol, 0.3 M NaCl, 10 mM
Tris, pH 8.0, 1 mM EDTA, pH 8.0) containing [35S]UTP-labeled
cRNA riboprobes (1 × 107 cpm/ml) in the antisense orientation.
Adjacent sections were incubated with riboprobes in the sense
orientation to define non-specific hybridization. Tissue sections
were then incubated with RNase A (20 µg/ml) for 30 min at
37◦C, followed by high-stringency washes of decreasing salinity
in SSC (sodium chloride/sodium citrate) buffer, and a 30 min
wash in 0.1× SSC at 60◦C. Sections were dehydrated, apposed to
β-max film for 3–6 days at 4◦C, and then dipped in liquid NTB-2
emulsion. Following a 2-week exposure, slide were developed
in Kodak D-19, fixed, counter-stained with Cresyl-Violet,
cover-slipped and analyzed by high-powered microscopy.
Data Analysis
An initial anatomical analysis was undertaken in which
autoradiographic images on β-max films were compared to their
corresponding Nissl-stained sections, at each developmental age.
Emulsion dipped slides were then analyzed by microscopy to
more accurately define areas expressing α7 mRNA. Labeled
anatomic regions of embryonic and postnatal mouse bodies
were identified using several different sources (Kaufman, 1995;
Jacobowitz and Abbott, 1998; Kaufman and Bard, 1999; Paxinos
et al., 2007). Silver grains in these regions were manually counted
at 400× magnification within a 2 × 2 grid area encompassing
50 µm2 and the results were expressed as the average number
of silver grains per single (25 µm2) grid box. Based on these
counts, a score was assigned to the labeled anatomical structure:
+ (>10 grains/25 µm2), ++ (>20 grains/25 µm2), +++
(>50 grains/25 µm2), ++++ (>90 grains/25 µm2). In some
regions, a double quantitative score was ascribed (e.g., +/+++),
which signified lower levels of mRNA surrounding spots of
more intense signal. Background labeling (<10 grains/25 µm2)
was established as the density of silver grains in non-neural
tissues with high cellular density (such as the liver), or with
high density of extracellular matrix (such as cartilage), or the
density of grains over neural structures after hybridization with
the sense riboprobe.
RESULTS
We began our analysis at E13 because it was previously
demonstrated that at this age, low levels of α7 nAChR mRNA
expression first appear in several regions of the rat brain (Broide
et al., 1995; Adams et al., 2002). However, because our present
analysis of the mouse was more broad-based, encompassing the
entire body, we conducted a more general investigation of the
CNS with greater emphasis on regions showing higher α7 mRNA
expression. An initial examination of autoradiographic images
revealed that α7 nAChR mRNA was expressed throughout the
CNS, including the spinal cord and retina, as early as E13, and
up until birth (Figure 1). High levels of mRNA transcripts were
also found in many PNS and sensory ganglia, and relatively low
levels of α7 mRNA labeling were detected in some non-neuronal
tissues during development. In general, at E13, α7 nAChR mRNA
expression intensity was low to moderate in the PNS and CNS,
and low in non-neuronal areas of the body (Figure 1 and
Tables 1–3). However, by E15, there was a marked increase
in mRNA expression intensity in areas of the nervous system
that persisted until birth, whereas expression in non-neuronal
areas remained low.
Central Nervous System
Olfactory Bulb
At E13, emulsion dipped, sagittal whole-body sections containing
the emerging olfactory bulb showed background labeling in this
region (Figure 2A). By E15, low levels of α7 nAChR mRNA
expression were first observed in the olfactory bulb and were
visible throughout embryonic development (Figures 2B,D and
Table 1). The olfactory tubercle exhibited higher levels of mRNA
expression that peaked slightly at E17 (Table 1).
Telencephalon
In the developing mouse telencephalon, α7 nAChR mRNA
was most prominently expressed in the neocortex and the
hippocampus (Figure 2 and Table 1). At E13, moderate levels of
α7 mRNA were already observed throughout the cortical plate
and the emerging hippocampal formation (Figure 2E). Levels of
α7 mRNA in these regions were increased by E15 and remained
high until birth (Figures 2F–H). In the neocortex, high levels
of α7 mRNA expression were largely restricted to the parietal
cortex. Elevated levels of mRNA were also expressed in the
emerging layer 6 of the cortex, beginning at E17 (Table 1). Lower
levels of mRNA labeling were observed in the intermediate and
ventricular zones, as well as the basal ganglia, preoptic area, and
the septum (Table 1).
Diencephalon
Levels of α7 nAChR mRNA in the diencephalon at E13
were extremely low (Table 1). However, by E15, mRNA levels
were increased in various nuclei throughout the thalamus and
hypothalamus, and remained at moderate levels until birth.
Mesencephalon
The developing mesencephalon is comprised of the superior and
inferior colliculi at its dorsal subdivision and the tegmentum,
including the red nucleus in the ventral subdivision. At E13,
mostly background labeling was observed in this region of the
brain (Table 1). Levels of α7 mRNA in the mesencephalon
showed a slight increase by E15 and remained relatively low
throughout embryonic development. However, higher levels of
mRNA were particularly notable in the red nucleus and the
superior and inferior colliculi (data not shown).
Pons
The region of the pons that contains the locus coeruleus (LC) and
dorsal raphe (DR), showed strong labeling for α7 nAChR mRNA
in the dorsal tegmental and ventral tegmental nuclei from E13
until birth (Figures 2I–L). Low to moderate levels of mRNA were
found throughout the rest of the pons (Table 1).
Frontiers in Neuroanatomy | www.frontiersin.org 3 August 2019 | Volume 13 | Article 76
fnana-13-00076 August 3, 2019 Time: 14:35 # 4
Broide et al. α7 Expression in Mouse Embryos
FIGURE 1 | Bright-field micrographs of autoradiographic images showing α7 nAChR mRNA expression in sagittal midline sections of E13 (B), E15 (D), E17 (F), and
P0 (H) mouse pups. (A,C,E,G) Adjacent sections stained with cresyl-violet. Strong mRNA labeling can be seen in the autonomic (arrowhead) and trigeminal (double
arrowheads) ganglia as well as the prostate (arrow). Di, diencephalon; H, heart; Me, mesencephalon; MO, medulla oblongata; Po, pons; SC, spinal chord; St,
stomach; Te, telencephalon. Scale bar = 1 mm (A,B), 1.5 mm (C,D), 1.7 mm (E,F), and 2 mm (G,H).
Medulla Oblongata
At E13, low levels of α7 nAChR mRNA expression were observed
in the medulla oblongata. However, by E15, levels of mRNA
were increased, particularly in the ventral region, and remained
elevated until birth (Table 1). The mRNA expression pattern was
mainly scattered with some dense areas of labeling in both the
dorsal and ventral regions (Figures 2I–L).
Cerebellum
The cerebellum, which was first visible by E15, showed very
low levels of α7 mRNA expression throughout embryonic
development (Figures 2I–L and Table 1).
Spinal Cord
Moderate levels of α7 mRNA expression were visible in the spinal
cord (SC) at E13 and remained relatively unchanged until birth
(Figures 2M–P and Table 1). In the dorsal region of the SC,
the expression of α7 mRNA was homogenous. However, in the
ventral region, a band of increased α7 mRNA expression was
observed with areas of intense cellular labeling (Figures 2M–P).
Retina
The developing retina exhibited background labeling at E13. By
E15, low levels of α7 mRNA expression became detectable in
the emerging ganglionic cell layer. Figure 3 shows an example
of α7 mRNA labeling in an E17 retina. This level of scattered
labeling, which was not found in adjacent sections hybridized
with the sense riboprobe (Figure 3C), was observed throughout
embryonic development and at birth.
Peripheral Nervous System
α7 nAChR mRNA was expressed in all discernible ganglia of
the developing mouse PNS. However, due to technical issues
in gathering tissue sections, not all ganglia were observed
at every age analyzed. Therefore, the representative ganglia
that are discussed are those that were visible throughout
embryonic development.
Sensory Ganglia
We examined two different sensory ganglia, the trigeminal and
the dorsal root ganglion. The trigeminal ganglion (TG) is a
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TABLE 1 | α7 nAChR subunit mRNA expression in the developing central
nervous system (CNS).
Age
Region E13 E15 E17 P0
Olfactory bulb – ++ ++ ++
Olfactory tubercle – +++ ++++ +++
Telencephalon
Parietal Cortex
Cortical plate +++ ++++ ++++ ++++
Layer 6 NA NA ++++ +++
Intermediate zone NA ++ ++ +
Ventricular zone – + + –
Hippo. formation ++ ++++ ++++ +++/++++
Septum – – + +
Basal ganglia + + +/++ +/++
Preoptic area ++ ++ ++ ++
Diencephalon
Thalamus
Lateral –/+ +/+++ +/++++ +/+++
Medial –/+ +/++ +/+++ +/+++
Hypothalamus –/+ +/++ +/+++ +/+++
Mesencephalon
Lateral – + +/++ +/++
Mediodorsal + + + ++
Medioventral – +/++ +/++ +/++
Pons
Lateral + +/++ +/++ +/++
Mediodorsal +/+++ +/++++ +/++++ +/++++
Medioventral + +/+++ +/+++ +/+++
Medulla oblongata
Lateral + ++ ++ ++
Mediodorsal +/++ ++/+++ ++/+++ ++/+++
Medioventral +/++ ++/++++ ++/++++ ++/+++
Cerebellum NA + + +
Spinal chord
Dorsal ++ +++ +++ +++
Ventral ++/+++ +++/++++ +++/++++ +++/++++
Intensity is based on silver grain counts: + (>10 grains/25 µm2), ++
(>20 grains/25 µm2), +++ (>50 grains/25 µm2), ++++ (>90 grains/25 µm2).
A double quantitative score indicates signified lower levels of mRNA surrounding
spots of more intense signal.
sensory ganglion found at the base of the brain. Primary afferent
fibers from this ganglion form much of the fifth cranial nerve (V),
which innervates the face, jaw and olfactory mucosa. At E13, the
TG exhibited low levels of α7 mRNA labeling (Figure 4A and
Table 2). By E15, levels of mRNA were markedly increased and
remained elevated until birth (Figures 4B–D and Table 2). The
α7 mRNA expression pattern in the TG appeared striated with
random cells expressing a higher density of mRNA transcripts.
The dorsal root ganglia (DRG) are attached to the dorsal horn
on either side, and along the length of the spinal cord. They
receive input from the various sensory receptors throughout
the body and relay this information to the spinal cord. At E13,
the DRG showed very low expression of α7 mRNA transcripts
TABLE 2 | α7 nAChR subunit mRNA expression in ganglia of the developing
peripheral nervous system (PNS).
Age
Ganglion E13 E15 E17 P0
Sensory
Trigeminal (V) ++ +++/++++ +++/++++ +++/++++
Dorsal root + +++/++++ +++/++++ +++/++++
Autonomic ganglia
Sympathetic
Superior cervical +++ ++++ ++++ ++++
Stellate +++ ++++ ++++ ++++
Celiac +++ ++++ ++++ ++++
Mesenteric +++ ++++ ++++ ++++
Parasympathetic
Submandibular (VII) +++ +++ +++ +++
Otic (IX) +++ ++++ ++++ ++++
Vagal (X) +/++ ++/++++ ++/++++ ++/++++
Intracardiac +++ +++ +++ +++
Intramural +++ ++++ ++++ +++
Enteric + +++ +++ ++/+++
Intensity is based on silver grain counts: + (>10 grains/25 µm2), ++
(>20 grains/25 µm2), +++ (>50 grains/25 µm2), and ++++ (>90 grains/25 µm2).
A double quantitative score indicates signified lower levels of mRNA surrounding
spots of more intense signal.
TABLE 3 | Expression of α7 nAChR subunit mRNA in developing non-neuronal
tissue.
Age
Tissue E13 E15 E17 P0
Adrenal medulla ++ +++ +++ +++/++++
Kidney cortex –/+ –/+++ –/+++ –/++
Tongue – –/+++ –/+++ –/++++
Nasal epithelium – + + +
Tooth bud – + ++ +
Aorta ++ ++ ++ ++
Muscle +/+++ +/++ + –
Intensity is based on silver grain counts: + (>10 grains/25 µm2), ++
(>20 grains/25 µm2), +++ (>50 grains/25 µm2), and ++++ (>90 grains/25 µm2).
A double quantitative score indicates signified lower levels of mRNA surrounding
spots of more intense signal.
(Figure 4E and Table 2). The levels of mRNA were markedly
increased by E15 and remained elevated until birth (Figures 4F–
H and Table 2). The α7 mRNA expression pattern in the DRG
was homogenous, with intermittent clusters of cells expressing a
high density of mRNA transcripts.
The vagal (jugular) ganglion (VG), located just behind
the cochlea, is a well-marked ganglionic enlargement of the
vagus nerve (X) complex that provides afferent somatosensory
innervation to the external auditory meatus, cranial meninges,
and the tympanic membrane. At E13, the vagal ganglion showed
very low levels of α7 mRNA expression (Figure 4M and Table 2).
By E15, the overall levels of α7 mRNA were increased to moderate
levels, and random cells were observed expressing very high
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FIGURE 2 | Dark-field photomicrographs showing α7 mRNA distribution in different regions of the CNS from parasagittal sections of E13, E15, E17, and P0 mouse
pups. (A–D) In the area of the olfactory bulb (OB), arrowheads point to increasing mRNA expression in the olfactory tubercle. (E–H) In the telencephalon (Te), strong
mRNA expression is observed in the parietal cortex (arrow) and hippocampus (arrowhead). (I–L) In the pons, the mRNA expression is highest in the dorsal tegmental
(arrowhead) and ventral tegmental (arrow) nuclei. (M–P) In the spinal cord (SC), a band of elevated mRNA expression can be seen in the ventral, motor neuron
region. Cb, cerebellum; CP, caudate putamen; MO, medulla oblongata; NA, neural arch; V, vertebrate. Scale bar = 300 µm.
FIGURE 3 | α7 nAChR mRNA distribution in the developing retina. (A,B) Bright- and dark-field photomicrographs of an E17 retina showing low levels of α7 mRNA
expression in the ganglion cell layer. The section was counterstained with cresyl-violet and retinal layers are indicated: GL, ganglion cell layer; NE, neural epithelium;
PE, pigment epithelium. (C) Adjacent section showing background labeling with the sense riboprobe. Scale bar = 50 µm.
mRNA levels. This pattern and level of expression persisted until
birth (Figures 4N–P and Table 2).
Autonomic Sympathetic Ganglia
The sympathetic chain of ganglia are located next to the vertebral
column and overlying the descending aorta. Together they
provide sympathetic innervation to all the organs of the body.
Although α7 nAChR mRNA labeling was observed throughout
the sympathetic chain, we focused primarily on the larger,
superior cervical ganglia (SCG), which are located at the top of
this chain and innervate the radial muscle of the iris, the eyelids,
the lacrimal and salivary glands, and the heart. At E13, the SCG
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FIGURE 4 | Dark-field photomicrographs of representative sensory and autonomic ganglia at E13, E15, E17, and P0. (A–D) Increasing α7 mRNA expression is
observed with age in the trigeminal sensory ganglion (TG) and the optic parasympathetic ganglion (arrowhead). (E–H) α7 mRNA expression in the dorsal root
ganglion (DRG) is low at E13, but shows intense punctate expression starting at E15. The entry point for the dorsal root is indicated (arrows). (I–L) An even
distribution of strong α7 mRNA expression is observed in the superior cervical ganglion (SCG), part of the chain of sympathetic ganglia along the spinal cord. (M–P)
Expression of α7 mRNA in the vagal parasympathetic ganglion (VG) at the base of the brain. Hy, hypothalamus; C, cochlea. Space bar = 250 µm (A–D),
100 µm (E–P).
exhibited moderate levels of α7 mRNA expression (Figure 4I and
Table 2). However, by E15, the levels of α7 mRNA in the SCG
were increased and remained high until birth (Figures 4J–L and
Table 2). The α7 mRNA expression pattern was homogenous
throughout the SCG. Similar spatiotemporal patterns of α7
mRNA expression were also observed in the stellate, celiac, and
mesenteric sympathetic ganglia (Table 2).
Autonomic Parasympathetic Ganglia
The parasympathetic ganglia are located close to the organs they
innervate and are often embedded within their walls. The cranial
component of the parasympathetic system originates from four
of the twelve cranial nerves that emerge from the brainstem. The
glossopharyngeal nerve (IX) synapses onto neurons in the otic
ganglion (OG) which innervates the parotid gland. Located just
below the TG, the OG exhibited moderate levels of α7 mRNA
expression at E13 (Figure 4A and Table 2). The levels of α7
mRNA were increased by E15 and remained high until birth
(Figures 4B–D and Table 2).
During embryonic development, α7 nAChR mRNA
transcripts were also detected in a number of parasympathetic
ganglia embedded within different organs (Table 2). For example,
α7 mRNA was expressed at moderate levels in intracardiac
ganglia that are interspersed on top of the atria of the heart
(Figures 5A,B). High levels of α7 mRNA expression were
also found in intramural ganglia surrounding the esophagus,
and were observed along its entire length (Figures 5C,D).
Moderate levels of α7 mRNA expression were detected in
submandibular ganglia which are embedded in the submaxillary
gland (Figures 5E,F), and are innervated by the facial nerve
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FIGURE 5 | Bright- and dark-field photomicrographs showing α7 nAChR mRNA expression in various intramural ganglia of the parasympathetic system at E15 and
E17. (A,B) α7 mRNA transcripts are expressed in intracardiac ganglia (arrowheads), that are interspersed on top of the atria. (C,D) Intramural ganglia (arrowheads)
lining the esophagus (E) showing high levels of α7 mRNA expression. (E,F) Expression of α7 mRNA is observed in one of the submandibular ganglia within the
submaxillary gland. (G,H) The enteric plexus of the large colon (area between dashed lines) shows light to moderate expression of α7 mRNA. Sections are
counterstained with cresyl-violet. A, atrium; CV, cardiac vessel; D, submaxillary duct; E, esophagus; EP, enteric plexus; M, mucosa; ME, muscularis externa; SM,
submucosa. Space bar = 50 µm.
(VII). Finally, ganglia in the enteric plexus of the gut displayed
low to moderate levels of α7 mRNA expression during embryonic
development. These ganglia were observed throughout the small
and large intestine (Figures 5G,H).
Non-neuronal Tissues
Adrenal Medulla and Kidney Cortex
In addition to the expression of α7 nAChR mRNA in the nervous
system, α7 mRNA transcripts were also detected in a number
of non-neuronal tissues throughout the bodies of embryonic
and postnatal mice. At E13, low levels of α7 nAChR mRNA
were detected in the adrenal medulla (Table 3). The mRNA
levels increased by E15 and were highest at birth. The mRNA
expression pattern delineated the adrenal medulla containing
darkly stained chromaffin cells (Figures 6A,B). Low levels of α7
mRNA transcripts were observed in the kidney cortex at E13. The
levels were notably increased by E15 followed by a slight decrease
at birth (Table 3). The signal was detected in tubules proximal
to the glomeruli (Figures 6C,D). Adjacent sections hybridized
with the sense riboprobe showed only background levels over the
tubules in the kidney cortex (Figures 6E,F).
Oral and Nasal Tissues
Transcripts for α7 nAChR mRNA were detected in several
different non-neuronal tissues in the head region of embryonic
and postnatal mice. These tissues all showed background labeling
at E13 (Table 3). However, by E15, moderate levels of α7 mRNA
expression were first observed in the posterior portion of the
tongue, above the frenulum, and were increased by P0. The
mRNA labeling exhibited a punctate chain pattern that was
confined to the middle region of the tongue (Figures 7A,B). Very
low levels of α7 mRNA labeling were also found in cells of the
nasal epithelium beginning at E15 and up until birth (Table 3
and Figures 7D,E). Finally, low levels of α7 mRNA transcripts
were first detected in the developing tooth bud at E15 and were
FIGURE 6 | Bright- and dark-field photomicrographs of the adrenal gland and
kidney cortex at E17 displaying α7 nAChR mRNA expression. (A,B) The
adrenal medulla shows high levels of α7 mRNA expression. (C,D) In the
kidney cortex, α7 mRNA is expressed mainly in tubules close to the glomeruli.
(E,F) Adjacent section showing background labeling with the sense riboprobe
in the kidney cortex. Sections are counterstained with cresyl-violet. C, adrenal
cortex; G, glomerulus; M, adrenal medulla; T, kidney tubule. Scale
bar = 100 mm (A,B), 25 µm (C–F).
markedly increased by birth (Table 3). The mRNA expression was
highest in the predentin layer of the tooth bud, an area containing
the extended cell bodies of the dentine-forming odontoblasts
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FIGURE 7 | Bright- and dark-field photomicrographs showing α7 nAChR mRNA expression in various non-neuronal tissues from E17 and P0 mouse pups. (A,B)
Strong punctate expression of α7mRNA in the posterior region of the tongue (arrow heads). (D,E) Low expression of α7mRNA is observed in the nasal epithelium.
(G,H) Moderate levels α7mRNA expression are observed in the predentin layer of the developing tooth bud. (J,K) α7 mRNA expression is shown in epithelial cells
lining the aorta. Sections are counterstained with cresyl-violet. (C,F,I,L) Adjacent sections showing background labeling in each tissue with the sense riboprobe. A,
aorta; CV, cardiac vessel; D, dentine; F, frenulum; NE, nasal epithelium; O, odontoblasts; P, palate; PD, predentin; T, tongue; TB, turbinate bone; V, ventricle. Space
bar = 250 µm (A–C), 25 µm (D–I), 100 µm (J–L).
(Figures 7G,H). Expression of α7 was also detected in the cell
line of the aorta (Figures 7J,K). Adjacent sections hybridized
with the sense probe exhibited background levels of expression
(Figures 7C,F,I,L).
Prostate and Testes
Male mouse pups were only identified and obtained at E17
and P0. Therefore, our analysis of the prostate and testes was
limited to these two ages. At E17, high levels of α7 nAChR
mRNA expression were observed in the developing prostate
(Figures 8A,B). This structure was located and identified just
below the iliac artery and slightly dorsal of the bladder in the
midline region. We also found low levels of α7 mRNA expression
within the seminiferous tubules of the testes (Figures 8C,D). This
labeling was not detected on adjacent sections hybridized with
the sense riboprobe (Figures 8E,F). The α7 mRNA transcripts
were expressed in the lumen of the tubules over cells with light
Nissl staining (Figures 8G,H). Female embryos showed only
background labeling over their ovaries (data not shown).
Muscle
Interestingly, we found α7 nAChR mRNA expression in
developing muscle tissue. However, in contrast to the other body
regions analyzed, the muscle showed a decrease in α7 mRNA
expression during embryonic development (Table 3). Beginning
at E13, low levels of α7 mRNA expression were observed over
most of the muscle regions, with low to moderate expression
levels exhibited in areas of the limbs close to the cartilage
(Figures 9A,B). By E17, only low levels of mRNA were apparent
over all muscle areas (Figures 9D,E) and by P0, these levels
were the same as background (Table 3). Adjacent sections show
hybridization signal with the sense probe (Figures 9C,F).
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FIGURE 8 | Bright- and dark-field photomicrographs showing α7 nAChR
mRNA expression in the prostate and testes at E17. (A,B) High expression of
α7 mRNA is observed in the mouse prostate, close to the iliac artery (IA). The
arrow points toward the bladder. (C,D) α7 mRNA labeling can be seen within
the seminiferous tubules (S) of the mouse testes. (E,F) Adjacent section
showing background labeling with the sense riboprobe in the testes. (G,H)
Higher magnification of tubules in C and E (asterisk) showing mRNA
expression on cells within the seminiferous tubule. Sections are
counterstained with cresyl-violet. Scale bar = 100 µm (A,B); 25 µm (C–F);
10 µm (G,H).
DISCUSSION
In the present study, we have demonstrated the widespread
distribution of α7 nAChR mRNA throughout the embryonic
mouse nervous systems, highlighting the ubiquitous expression
of α7 mRNA in the central, peripheral and enteric nervous
system during embryonic development. At E13, the youngest age
examined, α7 nAChR mRNA expression was already moderately
strong in most autonomic ganglia and spinal cord, and expression
was also detected at lower levels in the medulla oblongata,
pons and mesencephalon. After E13, α7 mRNA expression was
generally increased, especially in autonomic and parasympathetic
ganglia, and in cortical structures including the hippocampal
anlage, and became more refined to specific brain structures and
nuclei. These findings confirm previous studies in the rodent
(Broide et al., 1995; Messi et al., 1997; Adams et al., 2002), chick
(Erkman et al., 2000; Keiger et al., 2003), and human (Hellström-
Lindahl et al., 1998; Falk et al., 2002) developing nervous
system. Moreover, mRNA expression was observed in various
non-neural tissues throughout the body, including adrenal
medulla, kidney, tongue, tooth, nasal epithelium, prostate, testis
and muscle, but with the exception of the adrenal medulla,
expression levels were mostly low. This widespread expression
of α7 nAChRs throughout the developing nervous system and
the adrenal medulla suggest that these receptors might have
important functions during development and that prenatal
nicotine exposure may affect nervous system development via
aberrant activation of α7 nAChRs (Broide and Leslie, 1999),
which could particularly impact brain circuit formation (Lozada
et al., 2012) and alter adrenal medulla function (Buttigieg et al.,
2009). Additionally, there were low level of α7 mRNA expression
in many tissues throughout the body. However, it remains to
be determined if the transcripts are translated into protein and
subsequently form functional α7 nAChRs.
Technical Considerations
For this study, we utilized an in situ hybridization protocol
that was developed not only for its sensitivity but also for
specificity of signal (Winzer-Serhan et al., 1999). We employed
[35S]UTP-labeled cRNA riboprobes transcribed from a 279 bp
DNA fragment encoding the third intracellular loop of the mouse
α7 nAChR subunit for increased specificity. Riboprobes targeted
to this region have been used previously to characterize α7 mRNA
distribution in developing mice (Orr-Urtreger et al., 1995, 2000;
Broide et al., 2001), and show the same pattern of expression
as that observed using riboprobes targeted to the full length
mouse α7 nAChR mRNA that have been successfully used in
other studies (Broide et al., 1995; Bina et al., 1995; Adams et al.,
2002). BLAST analysis revealed no other highly homologous
sequences to non-α7 nAChR mouse transcripts, indicating that
the possibility of this cRNA probe to cross-hybridize with highly
homologous sequences is very low, and we are confident that
the hybridization signal shown throughout the embryonic mouse
body reflect α7 mRNA expression. While the number of embryos
in this study is limited to n = 2–3 per age, it must be emphasized
that the consistency in α7 nAChR expression within the outlined
structures from one age to the next provides an adequate number
overall that supports our findings for developmental expression
of this receptor.
Our study of α7 nAChR expression during mouse
development was focused on mRNA expression and not
protein. This was due to the fact that at the early prenatal time
points, the autoradiographic signal for [125I]α-BTX binding to
α7 receptor proteins in neuronal areas was barely detectable
above background. Furthermore, in the periphery, [125I]α-BTX
binds to muscle type nAChRs which makes it difficult to
distinguish binding to α7 receptors from binding to muscle-type
nAChRs. In addition, the use of α7 nAChR subunit antibodies
has proven unreliable because of the non-specific binding to
unknown sites that persist in α7 nAChR subunit knockout mice
(Moser et al., 2007). For this reason, publications describing
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FIGURE 9 | Bright- and dark-field photomicrographs showing α7 nAChR mRNA expression in muscle tissue at E13 and E17. (A,B) High expression of α7 mRNA is
observed in the inter-digit regions of the limb buds at E13. (D,E) Lower expression of mRNA is observed in these regions at E17. (C,F) Adjacent sections showing
background labeling with the sense riboprobe in the limb bud region. C, cartilage. Space bar = 100 µm.
expression of α7 nAChRs based on antibody staining or Western
blotting, are not discussed unless antibody specificity was verified
in α7 knockout mice. Therefore, in this study, we focused our
analysis on α7 subunit mRNA expression, and are conscious of
the fact that while α7 mRNA expression was observed within
the areas described herein, this expression may not translate
into subunit protein expression and formation of functional
α7 nAChRs. However, studies in the chick (Yu and Role, 1998;
Shoop et al., 1999; McNerney et al., 2000), rodent (Ospina et al.,
1998; Adams et al., 2002; Tribollet et al., 2004) and human
(Falk et al., 2002, 2003) have demonstrated expression of α7
nAChR binding sites in the CNS and PNS during embryonic
development. Nevertheless, the existence of functional α7
nAChRs in areas of low α7 mRNA expression, and in particular,
in non-neuronal tissue, is still unknown, and this issue was not
addressed in the current study.
Developmental Expression in Neuronal
Tissue
Central Nervous System and Spinal Cord
As early as E13, α7 mRNA expression was strong in the
telencephalon, in particular, within the cortical and hippocampal
anlage. This is in agreement with a previous study reporting that
α-BTX binding can first be detected in murine hippocampus
at E13 (Adams, 2003). Furthermore, a similar temporal and
spatial expression pattern has been described in rat hippocampus
(Adams et al., 2002). Thus, the results from this and other
studies suggest that α7 mRNA is translated into α7 nAChRs
at an early age, during embryonic cortical and hippocampal
development, but it is yet unclear if α7 nAChRs are functional
in these immature cortical structures. However, α7 nAChRs have
been implicated in hippocampal excitatory synapse formation,
suggesting a functional role for α7 nAChRs in the developing
hippocampus (Lozada et al., 2012), and there is evidence
that α7 nAChRs regulate GABAA receptor function and the
developmental GABAergic switch from excitation to inhibition
in ganglionic and hippocampal neurons (Liu et al., 2007).
In the spinal cord, another area of robust embryonic α7
nAChR expression, we found mRNA as early as E13, the youngest
time-point examined. A previous study had detected α-BTX
binding sites at E16 within rat spinal cord suggesting the presence
of α7 nAChRs (Tribollet et al., 2004). Furthermore, α7 mRNA
expression has been detected in human spinal cord derived
from 4 to 12-week-old embryos (Hellström-Lindahl et al., 1998).
Moreover, there is experimental evidence that spinal α7 nAChRs
are functional and facilitate excitatory neuronal transmission in
rat neonates (Genzen and McGehee, 2003; Cordero-Erausquin
et al., 2004). Thus, α7 nAChRs are expressed early in the
embryonic rodent and human spinal cord and may be involved
in the refinement of spinal cord circuits.
Peripheral Nervous System
The PNS serves as an essential relay between the brain and
spinal cord, and the rest of the body. Acetylcholine is the major
neurotransmitter in the PNS activating muscarinic and nicotinic
AChRs in different circuits. In the PNS, the main nAChR subtype
is composed of α3β4 subunits, and lack of this heteromeric
nAChR results in early postnatal death due to dysregulation
of vital body function (Xu et al., 1999; Wang et al., 2003).
In contrast, the role of α7 nAChRs in the PNS is not well
defined. In this study, we detected α7 mRNA expression in
dorsal root ganglia, sympathetic and parasympathetic ganglia,
and in the enteric plexus starting at E13, with intensity of
expression greatly increasing thereafter. Neonatal expression
of α7 nAChR transcripts has also been reported in mouse
superior cervical ganglion (Putz et al., 2008). Autoradiographic
analysis has shown I125-α-BTX binding to dorsal root ganglia,
superior cervical ganglion and sphenopalatine ganglion at E16
(Tribollet et al., 2004). Together these data suggest the presence
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of α7 nAChRs in the PNS during embryonic development.
Functional α7 nAChRs have been described in dorsal root ganglia
(Genzen et al., 2001; Smith et al., 2013) and different ganglionic
preparations (Cuevas and Berg, 1998; Yu and Role, 1998; Cuevas
et al., 2000; Li et al., 2009). In the embryonic avian ciliary
ganglion, neuronal responses to α7 nAChR activation result in
changes of intracellular calcium, which has been suggested to play
a role in cell survival within the developing autonomic nervous
system (Hruska and Nishi, 2007) and may help in synchronizing
transmission in the developing ganglion (Chang and Berg, 1999).
Furthermore, results from embryonic chick sympathetic neurons
suggest the possibility that α7 participates in forming functional
heteromeric nAChRs (Yu and Role, 1998). Heteromeric α7β2
nAChRs have since been detected in the brain but may also
exist in the PNS (Wu et al., 2016). Altogether, there is strong
expression of α7 mRNA and binding site, and ample evidence
for α7 nAChR mediated responses in the PNS. However, the
functional roles of α7 nACHRs in the PNS during development
and in adults are still not clearly defined.
Expression in the Enteric Nervous
System
Neuronal nAChRs are essential for fast excitatory
neurotransmission in the ENS, and the predominant nAChR
subtype mediating the synaptic transmission in the myenteric
plexus is the α3β4(α5) heteromeric nAChR ion channel (Galligan
and North, 2004). Functional responses mediated by heteromeric
nAChRs can be detected in the embryonic ENS at E12.5, and
greatly increase in intensity with age (Foong et al., 2015). In
contrast, the contributions of α7 nAChRs to ENS functions
remains ill defined, although, a potential role for α7 nAChRs
as modulator of transmitter release has been proposed (Obaid
et al., 2005). In the current study, transcripts for α7 nAChR
subunits were detected in the embryonic mouse gut starting at
E13 and increasing in intensity shortly thereafter. Similarly, in rat
myenteric plexus, expression of α7 nAChR subunit mRNA has
been detected in neonates (Garza et al., 2009). However, further
studies are needed to address the functional role of α7 nAChRs
in the mature and developing ENS.
Developmental Expression in
Non-neuronal Tissue
In mammals, neuroendocrine chromaffin cells are located in
the medulla of the adrenal glands, which is innervated by the
sympathetic splanchnic nerve. Release of acetylcholine triggers
the secretion of epinephrine and norepinephrine from the
adrenal gland via activation of heteromeric α3β4∗ nAChRs
(Yokotani et al., 2002). Although, α7 nAChRs have been detected
in the adrenal medulla, these receptors may not be involved
in catecholamine release but exert other functions (Mousavi
et al., 2001; Di Angelantonio et al., 2003; Sala et al., 2008;
Criado, 2018). In the present study, we detected α7 transcripts
in the embryonic adrenal medulla as early as E13, increasing
in intensity thereafter. Our results are in agreement with
another study using green fluorescent protein (GFP)-tagged α7
subunit expression demonstrating that GFP-immuno-reactivity
can be detected in embryonic precursor cells of the adrenal
gland as early as E12.5, and in chromaffin cells co-expressed
with tyrosine hydroxylase by E18.5 (Gahring et al., 2014).
Yet, the role of α7 nAChR in the embryonic adrenal gland
is not well understood. However, a functional role for α7
nAChRs during prenatal development can be inferred from a
chronic gestational nicotine exposure study where alterations
in oxygen sensitivity of adrenal chromaffin cells depended on
α7 nAChRs (Nurse et al., 2009). There is also evidence that
perinatal nicotine exposure alters KATP channel function in
chromaffin cells of the medulla through α7 nAChRs (Buttigieg
et al., 2009). Thus, further studies are needed to verify the
presence of functional α7 nAChRs in the developing and
mature adrenal gland.
The neuroendocrine chromaffin cells (or pheochromocytes)
of the adrenal medulla are derived from the neural crest
and are related to neurons in the peripheral and enteric
nervous system. Neural crest cells are also the precursor for
a diverse group of non-neuronal cells. For example, cranial
neural crest cells form the craniofacial mesenchyme which
differentiates not only into cranial ganglia but also into
craniofacial cartilage and bone (Selleck et al., 1993). Neural
crest cells contribute to thymus, bones of the middle ear
and jaw, and odontoblasts of the tooth primordia. Other
neural crest cells are located in the genital glands, the
epicardium, and in and around the kidneys. Interestingly,
in the mouse embryo, low levels of α7 mRNA expression
were detected in cells located within several of these tissues,
including tongue, tooth bud, kidney cortex, aorta, prostate
and muscle tissue, which are all related to the neural crest.
In support of our findings, other studies have also reported
expression of α7 during tooth development (Rogers and Gahring,
2012), in fetal muscle tissue (Fischer et al., 1999), and in a
subset of circumvallate taste bud cells in rat tongue tissue
(Qian et al., 2018). However, it is mostly unclear whether
α7 nAChR mRNA is translated into subunit protein and
subsequently into functional receptors. It is possible that α7
mRNA expression is only transient in many non-neuronal
cell types, as seen in muscle tissue, and that these low levels
of mRNA do not actually translate into functional receptors.
However, in support of functional receptors despite low level
of mRNA expression, there is evidence that α7 nAChRs
contribute to proper tooth development since knockout of α7
nAChRs results in altered adult mandibular incisors morphology
(Rogers and Gahring, 2012).
Lack of α7 Transcript Detection
In contrast to α7 mRNA hybridization signal found in kidney,
transcripts for α7 where not detected in other organs such as
heart (except for the expression in ganglia), liver, lung, spleen
and thymus. Our findings are in general agreement with a
recent study compiling tissue-specific expression patterns of α7
nAChR subunit in mouse tissues. Based on the Mouse ENCODE
transcriptome data set, expression of α7 nAChR mRNA in heart,
liver, spleen and thymus is extremely limited, with low level of
expression detected in adult kidney, lung, and testis in mice (Yue
et al., 2014). Similarly, low level of α7 mRNA expression was
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detected in human peripheral organs, although, more widespread
α7 protein expression was reported1.
Our data show a lack of α7 mRNA expression in thymus,
liver, spleen, and lung, with some expression found in the heart
that could be derived from intracardiac ganglia, and are in
contrast with others reporting expression of α7 nAChR mRNA
in heart (Dvorakova et al., 2005), lung (Sekhon et al., 1999), and
developing mouse thymus (Kuo et al., 2002). The reasons for
these discrepancies are not immediately clear, but may involve
different detection approaches. Several studies used RT-PCR
analysis (Kuo et al., 2002; Dvorakova et al., 2005). It cannot be
ruled out that mRNA derived from neurons in ganglia embedded
in organ tissues, or blood cells like macrophages, contributed to
amplification of α7 mRNA transcripts, or that alternative splice
variants are expressed which were not detected with our 279 bp
probe (Severance et al., 2004).
We expected to detect α7 nAChR mRNA expression in lung,
because there is evidence for functional α7 nAChRs in lung
bronchial epithelial cells (Wang et al., 2001; Fu et al., 2003, 2009),
and prenatal nicotine exposure affects lung function through α7
nicotinic receptors (Wongtrakool et al., 2012). A recent study
used a reporter mouse line which indirectly detected expression
of α7 nAChR subunits in mouse lung tissue (Gahring et al.,
2017). However, we did not detect hybridization signal in lung
tissue, which may reflect very low levels of expression in fetal
and neonatal lung.
Also puzzling was the lack of expression in the thymus
and spleen, organs that are related to the immune system.
The α7 nAChR plays a critical role in the cholinergic anti-
inflammatory pathway (Wang et al., 2003), and α7 expression
has been found in immune cells including lymphocytes and
macrophages (Skok et al., 2007; Fujii et al., 2017). A recent
study demonstrated expression in macrophages from α7 wildtype
but not knockout mice (Garg and Loring, 2019). RT-PCR
technology is a highly sensitive approach that detects even
minute numbers of transcripts that may go undetected with
the isotopic in situ hybridization approach. An alternative
explanation could be the age of the animals. Adult mice may
exhibit higher levels of α7 nAChRs expression in immune
system related tissues than fetal or neonatal tissues. However,
expression of α7 nAChR mRNA in spleen and thymus is also
very limited in adult mice (Yue et al., 2014). It is also possible
that the differentiated state of immune cells isolated from blood
affects expression of α7 mRNA, or that different splice variants
of α7 transcripts are expressed in circulating immune cells.
However, this conundrum still needs to be addressed, especially
with the increased focus on of α7 role in cholinergic anti-
inflammatory pathway.
CONCLUSION
The current study focused on α7 nAChR mRNA expression
in embryonic and neonatal tissues. The strongest expression
of α7 mRNA was detected in the PNS, including dorsal
1https://www.proteinatlas.org/ENSG00000175344-CHRN$\upalpha$7/tissue
root ganglia, parasympathetic and sympathetic ganglia,
followed by strong expression in brain and spinal cord. In
these structures, expression started at E13 and increased
in intensity thereafter. This neuronal expression pattern
generally corresponds to the distribution of alpha-BTX
binding to α7 homomeric nAChRs, as demonstrated by
other studies, suggesting the presence of α7 receptors,
and a functional role in the PNS, brain and spinal cord
during embryonic development. In addition, several reports
describe physiologically active α7 nAChRs in embryonic
chick ganglion neurons, (Yu and Role, 1998; Shoop et al.,
1999; McNerney et al., 2000). Furthermore, there is evidence
that α7 nAChRs regulate GABAA receptor function and the
developmental GABAergic switch from excitation to inhibition
in ganglionic and hippocampal neurons (Liu et al., 2007; Lozada
et al., 2012). Thus, nAChRs are expressed early during the
development of the peripheral and central nervous systems
and may guide important neurodevelopmental processes.
Little is known about α7 nAChRs in non-neuronal tissue
during development. Although α7 mRNA expression was
detected, it remains to be seen if functional receptors are
present in perinatal animals. There is a growing number
of studies describe anti-inflammatory effects mediated by
α7 nAChRs, however, expression of α7 mRNA in immune
system-related tissues during embryonic development was
below the sensitivity of the in situ hybridization approach
used in this study. Future functional studies need to determine
their role in the developing immune system. Altogether,
the presence of α7 nAChR mRNA within the regions
described herein may likewise indicate the concomitant
existence of protein, albeit at lower abundance outside of
the nervous system.
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